Libra Infusions Limited (DSE:LIBRAINFU)

Market Cap	1.44B -20.5%
Revenue (ttm)	197.03M -19.6%
Net Income	1.58M -68.2%
EPS	0.70 -68.2%
Shares Out	2.25M
PE Ratio	912.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,183
Open	645.10
Previous Close	643.90
Day's Range	640.00 - 649.80
52-Week Range	547.10 - 850.00
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Libra Infusions

Libra Infusions Limited manufactures and sells intravenous fluids in Bangladesh. Its products are used in medical situations, including diarrhoeal disease, surgical operation, loss of blood, weakness, and hospitalization. The company offers LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400, and LIBRET products. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was inc...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 699
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: LIBRAINFU

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 24, 2026

Data Sources Report a data error